GSK256073
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-119222-50 mg |
| CAS # | 862892-90-8 |
| Pricing | 50 mg, USD $1200.0 |
| Biological Activity | GSK256073 is a potent, selective and orally active GPR109A agonist and a long-lasting and non-flushing HCA2 full agonist with a pEC50 of 7.5 (human HCA2). GSK256073 acutely improves glucose homeostasis via inhibition of lipolysis and has the potential for the study of type 2 diabetes mellitus (T2DM)and dyslipidemia[1][2]. GPR109A: G-protein coupled receptor 109A; HCA2: hydroxy-carboxylic acid receptor 2 |
| Purity | ≥98.0% |
| MWt | 256.69 |
| Formula | C₁₀H₁₃ClN₄O₂ |